AI in life sciences raises various patent law considerations, including subject matter eligibility, novelty/obviousness, and ...

Sitryx CEO Iain Kilty describes the biopharmaceutical industry effort to go beyond immunosuppression in autoimmune and ...

IMMvention Therapeutix, Inc., an innovative biotechnology company based in Durham, has announced a strategic collaboration with Novo Nordisk A/S. This partnership aims to co-develop oral therapies for ...

A startup based in Research Triangle Park is making significant strides in transforming the tedious and time-consuming process of sample preparation, which is crucial in laboratory settings. Redbud ...

Rick Modi’s background in pharmacy gave him the scientific and analytical chops to pursue an MBA and ultimately lead innovative gene therapy companies.

The North Carolina Biotechnology Center leads life sciences economic development for North Carolina by supporting the progression of ideas from research lab to the marketplace. NCBiotech invests in ...

Ray Therapeutics' Co-Founder and CEO, Paul Bresge, joins Host Erin Harris to talk about optogenetics and how the company’s optogenetics approach differs from other gene therapies on the market ...

On this episode of the Business of Biotech, Life Science Leader's Ben Comer joins to co-host a conversation with Dr. Roet that goes deep on his company's genetic medicine approach to ALS, and even ...

A looming patent cliff is driving Big Pharma reorganization. Executives making career moves must understand differences in ...

Sponsored genetic testing programs can run afoul of federal laws, including the FCA and AKS, if not designed correctly. Experts at Morrison Foerster share best practices for compliance.